These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 25918297

  • 1. Evidence-Based Diagnostic Algorithm for Glioma: Analysis of the Results of Pathology Panel Review and Molecular Parameters of EORTC 26951 and 26882 Trials.
    Kros JM, Huizer K, Hernández-Laín A, Marucci G, Michotte A, Pollo B, Rushing EJ, Ribalta T, French P, Jaminé D, Bekka N, Lacombe D, van den Bent MJ, Gorlia T.
    J Clin Oncol; 2015 Jun 10; 33(17):1943-50. PubMed ID: 25918297
    [Abstract] [Full Text] [Related]

  • 2. Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation.
    Wick W, Meisner C, Hentschel B, Platten M, Schilling A, Wiestler B, Sabel MC, Koeppen S, Ketter R, Weiler M, Tabatabai G, von Deimling A, Gramatzki D, Westphal M, Schackert G, Loeffler M, Simon M, Reifenberger G, Weller M.
    Neurology; 2013 Oct 22; 81(17):1515-22. PubMed ID: 24068788
    [Abstract] [Full Text] [Related]

  • 3. Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution.
    Boots-Sprenger SH, Sijben A, Rijntjes J, Tops BB, Idema AJ, Rivera AL, Bleeker FE, Gijtenbeek AM, Diefes K, Heathcock L, Aldape KD, Jeuken JW, Wesseling P.
    Mod Pathol; 2013 Jul 22; 26(7):922-9. PubMed ID: 23429602
    [Abstract] [Full Text] [Related]

  • 4. Progress in the application of molecular biomarkers in gliomas.
    Wang J, Su HK, Zhao HF, Chen ZP, To SS.
    Biochem Biophys Res Commun; 2015 Sep 11; 465(1):1-4. PubMed ID: 26253473
    [Abstract] [Full Text] [Related]

  • 5. Predictive biomarkers in adult gliomas: the present and the future.
    Thomas L, Di Stefano AL, Ducray F.
    Curr Opin Oncol; 2013 Nov 11; 25(6):689-94. PubMed ID: 24076583
    [Abstract] [Full Text] [Related]

  • 6. Glioma biology and molecular markers.
    Cohen AL, Colman H.
    Cancer Treat Res; 2015 Nov 11; 163():15-30. PubMed ID: 25468223
    [Abstract] [Full Text] [Related]

  • 7. Clinical impact of molecular biomarkers in gliomas.
    Siegal T.
    J Clin Neurosci; 2015 Mar 11; 22(3):437-44. PubMed ID: 25533211
    [Abstract] [Full Text] [Related]

  • 8. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors.
    Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, Asai A, Kirino T.
    Clin Cancer Res; 2002 Jan 11; 8(1):196-201. PubMed ID: 11801559
    [Abstract] [Full Text] [Related]

  • 9. Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas.
    Xiong J, Liu Y, Wang Y, Ke RH, Mao Y, Ye ZR.
    Chin Med J (Engl); 2010 Dec 11; 123(24):3566-73. PubMed ID: 22166632
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impact of genetic targets on primary brain tumor therapy: what's ready for prime time?
    Zalatimo O, Zoccoli CM, Patel A, Weston CL, Glantz M.
    Adv Exp Med Biol; 2013 Dec 11; 779():267-89. PubMed ID: 23288644
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. IDH1 mutation of gliomas with long-term survival analysis.
    Myung JK, Cho HJ, Park CK, Kim SK, Phi JH, Park SH.
    Oncol Rep; 2012 Nov 11; 28(5):1639-44. PubMed ID: 22922798
    [Abstract] [Full Text] [Related]

  • 16. Loss of heterozygosity analysis in malignant gliomas.
    Mizoguchi M, Kuga D, Guan Y, Hata N, Nakamizo A, Yoshimoto K, Sasaki T.
    Brain Tumor Pathol; 2011 Jul 11; 28(3):191-6. PubMed ID: 21629980
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Updates in prognostic markers for gliomas.
    Aquilanti E, Miller J, Santagata S, Cahill DP, Brastianos PK.
    Neuro Oncol; 2018 Nov 09; 20(suppl_7):vii17-vii26. PubMed ID: 30412261
    [Abstract] [Full Text] [Related]

  • 19. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
    Dehais C, Laigle-Donadey F, Marie Y, Kujas M, Lejeune J, Benouaich-Amiel A, Pedretti M, Polivka M, Xuan KH, Thillet J, Delattre JY, Sanson M.
    Cancer; 2006 Oct 15; 107(8):1891-7. PubMed ID: 16986124
    [Abstract] [Full Text] [Related]

  • 20. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.